MedTrace Logo

The Efficacy of Botulinum Toxin in Spastic Neuropathic Bladder

NCT03407183 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2018-01-23

No results posted yet for this study

Summary

To assess the efficacy of botulinum toxin in spastic neurogenic bladder.

Conditions

  • Spastic Neurogenic Bladder

Interventions

PROCEDURE

intradetrusor injection of botulinumtoxinA (Botox)

intradetrusor injection of botulinumtoxinA (Botox®, Allergan, Irvine, USA) to assess the efficacy of Botox in treatment of neurogenic bladder.

Sponsors & Collaborators

  • AHMED FARAHAT HASSAN

    lead OTHER

Principal Investigators

  • AHMED FARAHAT, master · Assiut University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-02-01
Completion
2019-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03407183 on ClinicalTrials.gov